Suppr超能文献

[通过原位杂交对发育异常的进展与消退和人乳头瘤病毒DNA存在之间关系的回顾性分析]

[Retrospective analysis of relationship between progression and regression of dysplasia and existence of HPV DNA by in situ hybridization].

作者信息

Ebisawa K, Shinozuka T, Kawai K, Fujii A, Kuroshima Y

机构信息

Department of Obstetrics and Gynecology, Tokai University School of Medicine, Kanagawa.

出版信息

Nihon Sanka Fujinka Gakkai Zasshi. 1994 Oct;46(10):1041-8.

PMID:7814934
Abstract

We investigated the relationship between the progression and regression of cervical dysplasia and the existence of HPV DNA. The materials we analyzed were 80 biopsied specimens obtained from 22 cases of dysplasia which were followed-up for a long time at our out-patient clinic, and 47 specimens of squamous cell carcinoma. Detection of HPV DNA was done by in situ hybridization with biotinylated HPV DNA probes types 6/11, 16/18 and 31/33/35. The analysis of several specimens obtained at long term follow-up showed that the dysplasia-progression group had a higher incidence and more frequent detection of HPV DNA than the regression group. In the progression group, HPV 16/18 were detected more frequently than HPV 31/33/35 at the dysplasia lesion, but HPV 6/11 was detected in neither the dysplasia nor the squamous cell carcinoma. Fourteen of the 47 cases of squamous cell carcinoma (29.8%) were positive for HPV DNA, and 13 of them (92.9%) were detected in the lesions of dysplasia adjacent to carcinoma in situ or invasive cancer. Comparison of the detection rate for HPV DNA was done in the 3 dysplastic areas, i.e. the dysplastic areas in the dysplasia progression group (A), dysplasia regression group (B) and in the area adjacent to squamous cell carcinoma (C). The detection rates for HPV DNA were 43.5% in A, 27.7% in C and 15.0% in B. From these results we drew the following conclusions: 1) The continuous existence of HPV DNA, especially type 16/18 in the dysplasia lesions, may progress from lesions to carcinoma in situ or invasive cancer.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

我们研究了宫颈发育异常的进展与消退和人乳头瘤病毒(HPV)DNA存在之间的关系。我们分析的材料包括从22例发育异常病例获取的80份活检标本,这些病例在我们门诊进行了长期随访,以及47份鳞状细胞癌标本。采用生物素化的HPV 6/11、16/18和31/33/35型DNA探针进行原位杂交检测HPV DNA。对长期随访获取的多个标本进行分析显示,发育异常进展组HPV DNA的发生率更高且检测更频繁,高于消退组。在进展组中,发育异常病变处HPV 16/18的检测频率高于HPV 31/33/35,但在发育异常或鳞状细胞癌中均未检测到HPV 6/11。47例鳞状细胞癌中有14例(29.8%)HPV DNA呈阳性,其中13例(92.9%)在原位癌或浸润癌相邻的发育异常病变中检测到。在3个发育异常区域,即发育异常进展组的发育异常区域(A)、发育异常消退组(B)以及鳞状细胞癌相邻区域(C),对HPV DNA的检测率进行了比较。HPV DNA的检测率在A组为43.5%,在C组为27.7%,在B组为15.0%。从这些结果我们得出以下结论:1)HPV DNA的持续存在,尤其是发育异常病变中的16/18型,可能使病变进展为原位癌或浸润癌。(摘要截短至250字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验